Featured Sponsor

Featured Sponsor

More Reading

October 2008

Volume 6, Issue 10

Previous Months February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 August 2011 July 2011 June 2011 May 2011 April 2011 March 2011

Features

Feature Article: The Role of Cetuximab for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Ranee Mehra, MD, Roger B. Cohen, MD, and Barbara A. Burtness, MD

Categories: Head and Neck, Squamous Cell Carcinoma

Feature Article: Utility of Bortezomib Retreatment in Relapsed or Refractory Multiple Myeloma Patients: a Multicenter Case Series

Jeffrey Wolf, MD, Paul G. Richardson, MD, Michael Schuster, MD, Annette LeBlanc, Ian B. Walters, MD, David S. Battleman, MD, MSc

Categories: Myeloma

Clinical Case Study: An Aggressive Radio-Resistant Papillary Thyroid Cancer

Rohtesh S. Mehta, MD, MPh, Benjamin Negin, MD, Violeta Popii, MD, and Corey Langer, MD

Categories: Thyroid

Columns

Advances in LLM: Benefits of Minimal Residual Disease Negativity in the Therapy of Chronic Lymphocytic Leukemia

Neil E. Kay, MD

Categories: Leukemia, LLM

Advances in Hematology: Hemolytic Anemia Due to Warm Autoantibodies: New and Traditional Approaches to Treatment

Charles H. Packman, MD

Categories: Anemia, Hematology

Advances in Oncology: Cetuximab: Potential Role as First-line Treatment for Advanced Non-Small Cell Lung Cancer

Robert Pirker, MD

Categories: Lung, Oncology

Advances in Drug Development: Population Differences in the Use of EGFR-targeted Agents

Nagahiro Saijo, MD, PhD

Categories: Drug Development

In Focus: Renal Cell Carcinoma Update on the Use of mTOR Inhibitors in Renal Cell Carcinoma

Brian I. Rini, MD

Categories: Renal Cell Carcinoma

Hem/Onc News: Recent Clinical Findings

Ellie Vershvovsky

Categories: Brain, Colorectal, Drug Development, Head and Neck, Immunotherapy, Leukemia

CMExpress Opportunities